approaches driven by clinicians ......disorder test menu of more than 75 coagulation-specific...

4
COAGULATION ADVANCING THE DIAGNOSIS AND MANAGEMENT OF BLEEDING AND THROMBOSING DISORDERS

Upload: others

Post on 12-Nov-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: APPROACHES DRIVEN BY CLINICIANS ......disorder test menu of more than 75 coagulation-specific tests.} Accessing the experience and large coagulation-specific test volume, over 350,000

COAGULATIONADVANCING THE DIAGNOSIS AND MANAGEMENT OF BLEEDING AND THROMBOSING DISORDERS

Page 2: APPROACHES DRIVEN BY CLINICIANS ......disorder test menu of more than 75 coagulation-specific tests.} Accessing the experience and large coagulation-specific test volume, over 350,000

H E M A T O L O G Y A T M A Y O C L I N I C

M A Y O M E D I C A L L A B O R A T O R I E S . C O M / H E M A T O L O G Y

COMPREHENSIVE TESTING APPROACHES DRIVEN BY MAYO CLINIC RESEARCH AND PRACTICE FINDINGS

The Mayo Clinic Special Coagulation

Laboratory has been at the forefront of

research, testing, and treatment of patients

with bleeding and thrombosing disorders

for nearly 90 years. From pioneering

studies in thrombosis, hirudin, warfarin,

and vitamin K physiology to cutting-edge

platelet physiology, our reputation in the field

continues to grow.

WE ARE ABLE TO PROVIDE ACCURATE DIAGNOSES, IDENTIFY CLINICAL SIGNIFICANCE, AND PROVIDE OPTIMAL TREATMENT PATH BY:

} Offering a comprehensive coagulation disorder test menu of more than 75 coagulation-specific tests.

} Accessing the experience and large coagulation-specific test volume, over 350,000 performed annually, of Mayo Clinic clinicians and laboratorians to ensure broad expertise with rare cases.

} Integrating Mayo Clinic coagulation research to develop state-of-the-art tests and new testing procedures.

} Collaborating with the Mayo Comprehensive Hemophilia and Mayo Thrombophilia Centers, which treat more than 170 patients and 700 patients each year respectively, to assist in diagnosis and management of patients with hereditary or acquired bleeding or thrombosing disorders.

COLLEGIAL ACCESS TO MAYO CLINIC CLINICIANS, LABORATORIANS, AND GENETIC COUNSELORS

Mayo Medical Laboratories supports the local delivery of health care services, so when assistance with testing options, result interpretation, or case review and coordination is needed, Mayo Clinic clinicians, laboratorians, and genetic counselors are available to provide assistance. This rapport also provides the opportunity for general practice discussions among colleagues.

Telephone 855-516-8404Email [email protected]

CONSULTATIVE TEST PANELS FOR COMPLEX OR DIFFICULT DIAGNOSTIC PROBLEMS

THROMBOPHILIA PROFILE

ADAMTS13 ACTIVITY AND INHIBITOR PROFILE

BLEEDING DIATHESIS PROFILE

LUPUS ANTICOAGULANT PROFILE

PROLONGED CLOT TIME PROFILE

VON WILLEBRAND DISEASE PROFILE

Page 3: APPROACHES DRIVEN BY CLINICIANS ......disorder test menu of more than 75 coagulation-specific tests.} Accessing the experience and large coagulation-specific test volume, over 350,000

8 0 0 - 5 3 3 - 1 7 1 0 o r + 5 0 7 - 2 6 6 - 5 7 0 0

C O A G U L A T I O N

ADAMTS13 ACTIVITY AND INHIBITOR PROFILE (MAYO ID: ADM13)

} ADAMTS13 Activity Assay } ADAMTS13 Interpretation

Reflex Testing (performed if indicated): ADAMTS13 Inhibitor Screen, ADAMTS13 Inhibitor Bethesda Titer

BLEEDING DIATHESIS PROFILE (MAYO ID: BDIAL)

} Prothrombin Time

} Activated Partial Thromboplastin Time

} Thrombin Time

} Fibrinogen

} D-Dimer

} Soluble Fibrin Monomer

} Factor VIII Activity Assay

} von Willebrand Factor Antigen

} von Willebrand Factor Activity

} Factor XIII Screen

} Consultant Interpretation

Reflex Tests (performed if indicated): PT Mix 1:1, APTT Mix 1:1, Dilute Russell’s Viper Venom Time, DRVVT Mix, DRVVT Confirmation, Platelet

Neutralization Procedure, Reptilase Time, Coag Factor Assays (II, V, VII, X, VIII, IX, XI, XII), Factor Inhib Screens (II, V, VII, X, VIII, IX, XI), Bethesda

Units, Staclot LA, Alpha-2 Plasmin Inhibitor, Ristocetin Cofactor, von Willebrand Factor Multimer

LUPUS ANTICOAGULANT PROFILE (MAYO ID: LUPPR)

} Prothrombin Time

} Activated Partial Thromboplastin Time

} Dilute Russell’s Viper Venom Time

} Interpretation

Reflex Tests (performed if indicated): PT Mix 1:1, APTT Mix 1:1, DRVVT Mix, DRVVT Confirmation, Platelet Neutralization Procedure, Thrombin

Time (Bovine), Reptilase Time, Coag Factor Assays (II, V, VII, X, VIII, IX, XI, XII), Coag Factor VIII Assay Inhib Screen, Bethesda Units, Staclot LA,

Fibrinogen, D-Dimer, Soluble Fibrin Monomer, Consultant Interpretation

PROLONGED CLOT TIME PROFILE (MAYO ID: PROCT)

} Prothrombin Time

} Activated Partial Thromboplastin Time

} Dilute Russell’s Viper Venom Time

} Thrombin Time

} Fibrinogen

} D-Dimer

} Soluble Fibrin Monomer

} Consultant Interpretation

Reflex Tests (performed if indicated): PT Mix 1:1, APTT Mix 1:1, DRVVT Mix, DRVVT Confirmation, Platelet Neutralization Procedure, Reptilase

Time, Coag Factor Assays (II, V, VII, X, VIII, IX, XI, XII), Coag Factor VIII Assay Inhib Screen, Bethesda Units, Staclot LA

THROMBOPHILIA PROFILE (MAYO ID: THRMP)

} Prothrombin Time

} Activated Partial Thromboplastin Time

} Dilute Russell’s Viper Venom Time

} Thrombin Time

} Fibrinogen

} D-Dimer

} Soluble Fibrin Monomer

} Antithrombin Activity

} Protein C Activity

} Protein S Antigen, Free

} Prothrombin G20210A Mutation

} Activated Protein C Resistance

} Consultant Interpretation

Reflex Tests (performed if indicated): PT Mix 1:1, APTT Mix 1:1, Dilute Russell’s Viper Venom Time, DRVVT Mix, DRVVT

Confirmation, Platelet Neutralization Procedure, Reptilase Time, Coag Factor Assays (II, V, VII, X, VIII, IX, XI, XII), Factor Inhib Screens (II, V, VII, X,

VIII, IX, XI), Bethesda Units, Staclot LA, Alpha-2 Plasmin Inhibitor, Ristocetin Cofactor, von Willebrand Factor Multimer

VON WILLEBRAND PROFILE (MAYO ID: VWPR)

} Factor VIII Activity Assay

} Von Willebrand Factor Antigen

} Von Willebrand Activity

} Interpretation

Reflex Tests (performed if indicated): Coag Factor VIII Assay Inhib Screen, Bethesda Units, Ristocetin Cofactor, von Willebrand Factor Multimer,

Consultant Interpretation

COAGULATION DISORDER PROFILES

Page 4: APPROACHES DRIVEN BY CLINICIANS ......disorder test menu of more than 75 coagulation-specific tests.} Accessing the experience and large coagulation-specific test volume, over 350,000

MC2775-44rev1114

@mayocliniclabs/mayocliniclabsnews.mayomedicallaboratories.commayomedicallaboratories.com

HEMATOPATHOLOGISTS1 DONG CHEN, M.D., PH.D., Co-Director RONG HE, M.D.

HEMATOLOGISTS ANEEL A. ASHRANI, M.D. MICHELLE A. ELLIOT, M.D. CHRISTOPHER C. HOOK, M.D. JOHN A. LUST, M.D., PH.D. MRINAL S. PATNAIK, MBBS WILLIAM L. NICHOLS, JR., M.D. ANIMESH PARDANANI, MBBS, PH.D.2 RAJIV K. PRUTHI, MBBS, Co-Director

CARDIOLOGISTS3 JOHN A. HEIT, M.D., Co-Director ROBERT D. MCBANE, M.D. WALDEMAR E. WYSOKINSKI, M.D., PH.D.

CLINICAL PATHOLOGIST4 GRETCHEN JOHNS, M.D., Co-Director, Florida

PEDIATRIC HEMATOLOGY/ONCOLOGY DEEPTI M. WARAD, MBBS

EXPERTISE AT MAYO CLINIC

The Mayo Clinic Special Coagulation Laboratory

is led by the expertise of:

} Physician directors with experience in hematology, hematopathology, cardiovascular, molecular genetics, platelet function and electron microscopy, and protein chemistry.

} Consulting hematologists, cardiovascular specialists, and hematopathologists with expertise and interest in clinical and laboratory hemostasis and thrombosis to provide test panel interpretation and consultation.

} Clinical technical coagulation specialists able to assist clients with questions regarding appropriate testing, specimen requirements, and interpretation of results.

FOR MORE INFORMATION ABOUT COAGULATION TESTING, VISITMayoMedicalLaboratories.com/hematology

1 2

3 4